These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 698557

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.
    Bassendine MF, Chadwick RG, Salmeron J, Shipton U, Thomas HC, Sherlock S.
    Gastroenterology; 1981 May; 80(5 pt 1):1016-22. PubMed ID: 7009310
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of the antiviral effects of adenine arabinoside on chronic HBV infection.
    Watanabe S, Saito S, Yoshikawa A, Shibayama T, Kamimura T, Suzuki S, Ischida F.
    Hepatogastroenterology; 1982 Jun; 29(3):102-5. PubMed ID: 7106692
    [Abstract] [Full Text] [Related]

  • 5. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B.
    Scullard GH, Smith CI, Merigan TC, Robinson WS, Gregory PB.
    Gastroenterology; 1981 Dec; 81(6):987-91. PubMed ID: 7286593
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dane particles and associated DNA-polymerase activity in saliva of chronic hepatitis B carriers.
    Macaya G, Visoná KA, Villarejos VM.
    J Med Virol; 1979 Dec; 4(4):291-301. PubMed ID: 541682
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antiviral treatment of chronic hepatitis B virus infection: improvement in liver disease with interferon and adenine arabinoside.
    Scullard GH, Andres LL, Greenberg HB, Smith JL, Sawhney VK, Neal EA, Mahal AS, Popper H, Merigan TC, Robinson WS, Gregory PB.
    Hepatology; 1981 Dec; 1(3):228-32. PubMed ID: 6169615
    [No Abstract] [Full Text] [Related]

  • 12. Effect of vidarabine on chronic hepatitis B virus infection.
    Pollard RB, Smith JL, Neal A, Gregory PB, Merigan TC, Robinson WS.
    JAMA; 1978 Apr 21; 239(16):1648-50. PubMed ID: 633577
    [No Abstract] [Full Text] [Related]

  • 13. Infectivity markers in HBsAg chronic carriers and intrafamilial spread of hepatitis B virus infection.
    Pastore G, Dentico P, Angarano G, Lapedota E, Schiraldi O.
    Hepatogastroenterology; 1981 Feb 21; 28(1):20-2. PubMed ID: 7216135
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic effect of a low dosage of human leukocyte interferon on chronic hepatitis B virus infection.
    Matsumura N, Yoshikawa T, Kondo M, Kawakami H, Kishida T.
    Digestion; 1983 Feb 21; 26(4):205-12. PubMed ID: 6873506
    [Abstract] [Full Text] [Related]

  • 15. Randomized controlled trial of quinacrine for the treatment of HBsAg-positive chronic hepatitis.
    Bodenheimer HC, Schaffner F, Vernace S, Hirschman SZ, Goldberg JD, Chalmers T.
    Hepatology; 1983 Feb 21; 3(6):936-8. PubMed ID: 6354904
    [Abstract] [Full Text] [Related]

  • 16. The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection.
    Perrillo R, Campbell C, Wellinghoff W, Gelb L.
    Am J Gastroenterol; 1982 Jul 21; 77(7):445-9. PubMed ID: 7091131
    [Abstract] [Full Text] [Related]

  • 17. Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.
    Weller IV, Lok AS, Mindel A, Karayiannis P, Galpin S, Monjardino J, Sherlock S, Thomas HC.
    Gut; 1985 Jul 21; 26(7):745-51. PubMed ID: 2410328
    [Abstract] [Full Text] [Related]

  • 18. [Usefulness of the determination of DNA polymerase activity of hepatitis B virus in chronic HBsAg carriers].
    Carreño García V, Porres Cubero JC, Mora Pérez I, Hernańdez Guío C.
    Rev Clin Esp; 1985 Jul 21; 174(3-4):75-7. PubMed ID: 6515078
    [No Abstract] [Full Text] [Related]

  • 19. e-Antigen: a link between immune response and infectivity in hepatitis B?
    Turner GC, Green HT, Blundell VD.
    J Hyg (Lond); 1978 Dec 21; 81(3):405-14. PubMed ID: 731022
    [Abstract] [Full Text] [Related]

  • 20. Persistence of hepatitis B virus DNA demonstrated by polymerase chain reaction in serum and liver after loss of HBsAg induced by antiviral therapy.
    Marcellin P, Martinot-Peignoux M, Loriot MA, Giostra E, Boyer N, Thiers V, Benhamou JP.
    Ann Intern Med; 1990 Feb 01; 112(3):227-8. PubMed ID: 2297196
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.